[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367482-105":59,"doc-detail-367482-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","unraveling-drug-resistance-mechanisms-in-testicular-cancer-through-immune-cell-phenotypes-a-bidirectional-mendelian-randomization-analysis-revealing-novel-therapeutic-targets","Unraveling drug resistance mechanisms in testicular cancer through immune cell phenotypes - a bidirectional Mendelian randomization analysis revealing novel therapeutic targets","","Objective: address drug resistance in relapsed or refractory testicular cancer by testing immune-related causal effects. Method: perform a two-sample bidirectional Mendelian Randomization using 731 immune cell phenotypes, applying IVW, MR-Egger, weighted median, and additional models with public genetic datasets. Sensitivity analyses evaluate robustness and pleiotropy. Results: identify 12 immune phenotypes linked to disease risk and 16 phenotypes altered by disease, with markers aligning to known drug-resistance pathways. Conclusion: immune mechanisms may yield novel therapeutic targets and guide future strategies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unraveling-drug-resistance-mechanisms-in-testicular-cancer-through-immune-cell-phenotypes-a-bidirectional-mendelian-randomization-analysis-revealing-novel-therapeutic-targets/367482/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unraveling-drug-resistance-mechanisms-in-testicular-cancer-through-immune-cell-phenotypes-a-bidirectional-mendelian-randomization-analysis-revealing-novel-therapeutic-targets/367482.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why does this study focus on drug resistance in testicular cancer?","Question",{"text":113,"@type":114},"Relapsed or refractory testicular cancer remains difficult to treat due to drug resistance, creating a need to understand underlying mechanisms and potential interventions.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was causal inference performed in this research?",{"text":118,"@type":114},"The study used two-sample bidirectional Mendelian Randomization based on genetic variation as an instrumental variable, applying methods such as IVW and MR-Egger.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the results reveal about immune cell phenotypes?",{"text":122,"@type":114},"The analysis found immune phenotypes causally associated with testicular cancer development and phenotypes significantly modulated by the disease, including markers linked to known drug-resistance pathways.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},367482,1790196212,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Analysis  \nUnraveling drug resistance mechanisms in testicular cancer through immune cell phenotypes: a bidirectional Mendelian randomization analysis revealing novel therapeutic targets  \nLin Xiao1 · Tianen Wu1  \nReceived: 15 January 2025 / Accepted: 19 May 2025  \n© The Author(s) 2025 OPEN  \nAbstract  \nObjective While testicular cancer is highly curable, drug resistance remains a challenge in relapsed or refractory cases. This study explores the immune system’s role in resistance mechanisms via bidirectional Mendelian Randomization (MR) analysis of 731 immune cell phenotypes.  \nMethod We conducted a two-sample bidirectional MR analysis using IVW, MR-Egger, weighted median, and other models, leveraging public genetic datasets. Sensitivity analyses were performed to ensure robustness and assess pleiotropy. Results The MR analysis revealed 12 immune cell phenotypes causally linked to testicular cancer development and 16 phenotypes significantly modulated by the disease, highlighting potential therapeutic resistance mechanisms. Several identified immune markers were associated with known drug resistance pathways, suggesting novel therapeutic targets. Sensitivity analyses confirmed the robustness of our primary findings and their relevance to drug resistance mechanisms. Conclusion Our findings reveal immune-related mechanisms underlying drug resistance in testicular cancer, offering potential targets for overcoming therapeutic resistance and guiding future treatment strategies.  \nKeywords Immune cell phenotypes · Testicular cancer · Bidirectional · Mendelian randomization · Causal relationship  \nAbbreviations  \nMR Mendelian Randomization  \nIVW Inverse Variance Weighted TGCT Testicular germ cell tumors IV Instrumental Variable  \nGWAS Genome-Wide Association Studies SNPs Single Nucleotide Polymorphisms OR Odds Ratio  \nCI Confidence Interval  \nLin Xiao and Tianen Wu contributed equally to this work.  \nSupplementary Information The online version contains supplementary material available at [https://doi.org/10.1007/s12672-025-](https://doi.org/10.1007/s12672-025-)[ ](https://doi.org/10.1007/s12672-025-)[02757-z](02757-z.)[.](02757-z.)  \n* Lin Xiao, [maoxianwang888@126.com](maoxianwang888@126.com); Tianen Wu, [w857379@163.com |](w857379@163.com |1Department of Urology)[1](w857379@163.com |1Department of Urology)[Department of Urology](w857379@163.com |1Department of Urology), Jinjiang Municipal Hospital, Quanzhou 362200, Fujian Province, China.  \nDiscover Oncology  \n(2025) 16:912  \n| [https://doi.org/10.1007/s12672-025-02757-z](https://doi.org/10.1007/s12672-025-02757-z)  \n1 Introduction  \nTesticular cancer, acknowledged as the leading form of solid tumor among young adult men [1, 2], is experiencing a steady increase in cases, especially within developed countries [3] . Despite the ambiguity surrounding its causation and the heterogeneity in its pathological presentations, a significant majority (90% to 95%) of cases are categorized as testicular germ cell tumors (TGCT). Surgical treatments, frequently paired with chemotherapy, have demonstrated exceptional efficacy, attaining a remarkable 98% 5-year rate of survival for the disease’s localised stages. Nevertheless, the landscape of treatment is not devoid of hurdles; primary drug resistance, post-treatment disease progression, and the adverse impacts of therapeutic interventions pose substantial clinical challenges [4–6]. Moreover, the lingering longterm sequelae and the elusive nature of the disease’s origin necessitate a more profound investigation into potential risk factors. This approach, aimed at unveiling novel preventive measures and more precise treatment modalities, aims to reduce the disease’s potential future healthcare costs.  \nThe development of cancer depends critically on immune cells in the tumour microenvironment, a fact highlighted by the effectiveness of immunotherapy against various cancers [7, 8] . Although the blood-testis barrier traditionally positions the te","cbCaifoPPrQPKMs3","https://ap.wps.com/l/cbCaifoPPrQPKMs3","pdf",1245933,"English","# Introduction\n## Immune infiltration and immunotherapy context\n## Bidirectional Mendelian randomization framework\n## Study aim and expected contributions","[{\"question\":\"Why does this study focus on drug resistance in testicular cancer?\",\"answer\":\"Relapsed or refractory testicular cancer remains difficult to treat due to drug resistance, creating a need to understand underlying mechanisms and potential interventions.\"},{\"question\":\"How was causal inference performed in this research?\",\"answer\":\"The study used two-sample bidirectional Mendelian Randomization based on genetic variation as an instrumental variable, applying methods such as IVW and MR-Egger.\"},{\"question\":\"What did the results reveal about immune cell phenotypes?\",\"answer\":\"The analysis found immune phenotypes causally associated with testicular cancer development and phenotypes significantly modulated by the disease, including markers linked to known drug-resistance pathways.\"}]","Unraveling drug resistance mechanisms in testicular cancer through immune cell phenotypes - a bidirectional Mendelian randomization analysis revealing novel therapeutic targets | PDF",1790171003,23,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/118c89f57d7b91ef9115830d8076ed8b.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16c55e2f37a8297a4927dc55844dc77a.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3529f7d93acce01127abd7100dcb960e.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28dd9e8d5e377f1576088669cbc063ab.webp",980,1301]